XJPX2483
Market cap39mUSD
Jan 16, Last price
1,850.00JPY
1D
0.98%
1Q
-3.09%
Jan 2017
6.17%
IPO
-63.37%
Name
Honyaku Center Inc
Chart & Performance
P/E
8.68
P/S
0.55
EPS
213.15
Div Yield, %
2.43%
Shrs. gr., 5y
—
Rev. gr., 5y
3.88%
Revenues
11.30b
+3.25%
Net income
711m
+3.57%
CFO
754m
+102.01%
Dividend
Mar 28, 20250 JPY/sh
Profile
Honyaku Center Inc. provides translation services in Japan and internationally. It offers translation for patent documents comprising application-related, court-related, and others; and medical documents, including basic research/non-clinical development, clinical development, regulatory submission, and post-marketing. The company also provides financial and legal translations comprising finance, legal, disclosure and related documents, and corporate and other documents; and translation services for IT related documents and manuals documents. In addition, it offers translation of industrial documents, such as R&D, planning, and design documents; production, quality assurance, implementation, and maintenance service documents; sales and marketing documents; and non-manufacturing industry related documents. Further, the company provides medical writing, grammar check, transcription, staffing, multilingual contact center, proofreading and back translation, and foreign patent application services, as well as services related to computer games, e-learning, and Websites; and prepares drawings. Additionally, it offers translation services for documents required to apply for marriage, work, residency, study abroad, and other visas; and DTP, printing, document, and e-book translation related services, as well as pamphlets and catalogues, press releases and newsletters, and presentation documents. The company serves clients in a range of industries, such as auto, mechanical, electronics, pharma, patent, law, finance, R&D, education, and other fields. Honyaku Center Inc. was incorporated in 1986 and is headquartered in Osaka, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | |||||
Revenues | 11,303,974 3.25% | 10,947,849 5.91% | 10,337,326 4.30% | ||
Cost of revenue | 5,990,729 | 5,860,167 | 5,429,412 | ||
Unusual Expense (Income) | |||||
NOPBT | 5,313,245 | 5,087,682 | 4,907,914 | ||
NOPBT Margin | 47.00% | 46.47% | 47.48% | ||
Operating Taxes | 294,402 | 274,016 | 265,227 | ||
Tax Rate | 5.54% | 5.39% | 5.40% | ||
NOPAT | 5,018,843 | 4,813,666 | 4,642,687 | ||
Net income | 711,227 3.57% | 686,739 19.81% | 573,179 387.01% | ||
Dividends | (150,155) | (133,243) | (66,541) | ||
Dividend yield | 2.18% | 2.46% | 1.35% | ||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | 221,885 | 174,592 | 167,818 | ||
Net debt | (5,017,530) | (4,487,269) | (4,208,326) | ||
| Cash flow | |||||
Cash from operating activities | 753,963 | 373,228 | 830,308 | ||
CAPEX | (4,000) | (10,674) | (21,668) | ||
Cash from investing activities | (60,124) | (28,504) | (54,169) | ||
Cash from financing activities | (150,155) | (133,243) | (66,927) | ||
FCF | 4,896,671 | 4,479,336 | 4,883,621 | ||
| Balance | |||||
Cash | 4,691,074 | 4,133,859 | 3,899,282 | ||
Long term investments | 326,456 | 353,410 | 309,044 | ||
Excess cash | 4,452,331 | 3,939,877 | 3,691,460 | ||
Stockholders' equity | 5,787,873 | 5,274,350 | 4,706,411 | ||
Invested Capital | 2,020,529 | 1,794,148 | 1,315,169 | ||
ROIC | 263.13% | 309.63% | 321.19% | ||
ROCE | 82.08% | 88.41% | 97.59% | ||
| EV | |||||
Common stock shares outstanding | 3,341 | 3,335 | 3,330 | ||
Price | 2,060.00 27.00% | 1,622.00 9.52% | 1,481.00 0.20% | ||
Market cap | 6,882,256 27.24% | 5,408,698 9.69% | 4,931,049 0.32% | ||
EV | 1,864,726 | 921,429 | 722,723 | ||
EBITDA | 5,351,278 | 5,120,993 | 4,946,045 | ||
EV/EBITDA | 0.35 | 0.18 | 0.15 | ||
Interest | |||||
Interest/NOPBT | |||||